Pain and Analgesic Mechanisms
Section Editors: Martin Angst/Jianren Mao
Resveratrol Regulates N-Methyl-D-Aspartate Receptor
Expression and Suppresses Neuroinflammation in
Morphine-Tolerant Rats
Ru-Yin Tsai, PhD,*† Kuang-Yi Chou, PhD,† Ching-Hui Shen, MD, PhD,‡ Chih-Cheng Chien, MD, PhD,*
Wei-Yuan Tsai, MS,§ Ya-Ni Huang, PhD, Pao-Luh Tao, PhD,¶ Yaoh-Shiang Lin, MD,#
and Chih-Shung Wong, MD, PhD**
BACKGROUND: In the present study, we examined the effects and mechanisms of the Chinese
herb resveratrol on attenuation of morphine tolerance in rats.
METHODS: Male Wistar rats were implanted with 2 intrathecal catheters; one catheter was
connected to a mini-osmotic pump, used for either morphine (15 g/h) or saline (1 L/h)
infusion for 5 days. On day 5, resveratrol (7.5, 15, 30, or 60 g), dimethyl sulfoxide (5 L), or saline
(5 L) was injected via the other catheter immediately after the discontinued morphine infusion.
Three hours later, intrathecal morphine (15 g in 5 L saline) was given. All rats received the
nociceptive tail-flick test every 30 minutes for 120 minutes after the morphine challenge.
RESULTS: Long-term morphine infusion induced antinociceptive tolerance and up-regulated
N-methyl-D-aspartate receptor (NMDAR) subunit NR1 and NR2B expression in the synaptosome
fraction of the tolerant spinal cord dorsal horn. Resveratrol pretreatment provided a significant
antinociceptive effect of morphine in morphine-tolerant rats, and it was associated with reversal
of the up-regulated NR1 and NR2B subunits in the synaptosome fraction of morphine-tolerant rat
spinal cords. NR1/NR2B-specific antagonist ifenprodil treatment produced a similar effect as
that of resveratrol. Furthermore, an increase of postsynaptic density-95/NR1/NR2B complex
immunoprecipitation in morphine-tolerant rat spinal cord was also inhibited by resveratrol
pretreatment. Moreover, chronic morphine infusion activated glial cells with an increase of
proinflammatory cytokine tumor necrosis factor-, interleukin-1, and interleukin-6 mRNA
expression in morphine-tolerant rat spinal cords and these effects were suppressed by
resveratrol pretreatment before the morphine challenge.
CONCLUSIONS: Resveratrol attenuates morphine tolerance by inhibiting neuroinflammation and
down-regulating NMDAR NR1 and NR2B subunit expression. Resveratrol regulates the
NMDAR expression, which might be involved in a loss of scaffolding postsynaptic density-95
protein. (Anesth Analg 2012;115:944 –52)
M
orphine is a powerful analgesic for treating mod-
erate to severe pain. However, long-term mor-
phine administration induces tolerance, which
hampers its clinical use. Morphine tolerance is a complex
physiological response, which includes opioid receptor
uncoupling,
1
and endocytosis/desensitization,
2
increased
binding of -arrestin to opioid receptor,
3
glutamatergic
receptor activation,
4
and neuroinflammation.
5,6
The glutama-
tergic receptor system, especially the N-methyl-d-aspartate
receptor (NMDAR), is tetrameric hetero-oligomers consist-
ing of the essential NR1 subunit and 1 modulatory
NR2A–D and NR3 subunit. Activation of spinal NMDARs
has a crucial role in the development of morphine toler-
ance
7,8
and neuropathic pain.
9
Pharmacological blockade of
NMDARs or disruption of the NR1 subunit gene signifi-
cantly attenuates morphine tolerance.
10,11
The postsynaptic
density (PSD) protein family, particularly PSD-95, is critical
for anchoring NMDAR NR2 subunits in the postsynaptic
membrane, which triggers many physiological and patho-
logical responses.
12,13
Resveratrol (trans-3,4',5-trihydroxystilbene) is a natural
polyphenolic compound found in a large number of plants
as components of the human diet, including peanuts,
mulberries, grapes, and red wine. Evidence suggests that
resveratrol has several beneficial biological effects such as
antioxidation,
14
neuroprotection,
15,16
anticancer, antiin-
flammation, and cardioprotection.
17
It has no known toxic
side effects.
18
Resveratrol suppresses synthesis of proin-
flammatory mediators by inhibiting cyclooxygenase and
lipoxygenase pathways, which implies that resveratrol may
have analgesic activity.
19 –21
Moreover, in a carrageenan-
induced inflammatory model, resveratrol reversed thermal
Author affiliations are provided at the end of the article.
Accepted for publication April 20, 2012.
Supported by a grant from the National Science Council (NSC-98-2314-B-
281-002-MT3) and the Cathay General Hospital, Taipei, Taiwan (CGH-MR-
10010).
The authors declare no conflicts of interest.
Chih-Shung Wong, MD, PhD, is currently affiliated with the Department of
Anesthesiology, Cathay General Hospital, Taipei, Taiwan.
Reprints will not be available from the authors.
Address correspondence to Chih-Shung Wong, MD, PhD, Department of
Anesthesiology, Cathy General Hospital, 280, Renai Rd., Section 4, Taipei,
Taiwan. Address e-mail to w82556@gmail.com.
Copyright © 2012 International Anesthesia Research Society
DOI: 10.1213/ANE.0b013e31825da0fb
944 www.anesthesia-analgesia.org October 2012 • Volume 115 • Number 4